Dustin Boothe
Overview
Explore the profile of Dustin Boothe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Torgeson A, Lloyd S, Boothe D, Cannon G, Garrido-Laguna I, Whisenant J, et al.
Ann Surg Oncol
. 2017 Oct;
24(13):4001-4008.
PMID: 29043526
Background: Unresected extrahepatic cholangiocarcinoma (uEHCC) remains a deadly disease. Guidelines for uEHCC recommend either chemotherapy alone (CT) or chemoradiotherapy (CRT). This study used the National Cancer Database (NCDB) to compare...
12.
Gan M, Boothe D, Neklason D, Samadder N, Frandsen J, Keener M, et al.
J Gastrointest Oncol
. 2017 Sep;
8(4):643-649.
PMID: 28890814
Background: The outcomes, complications, and rates of secondary malignancies from radiation therapy (RT) are not known for patients with familial adenomatous polyposis (FAP). Methods: We queried the Hereditary Gastrointestinal Cancer...
13.
Torgeson A, Boothe D, Poppe M, Suneja G, Gaffney D
Gynecol Oncol
. 2017 Aug;
147(2):320-328.
PMID: 28802765
Purpose: Elderly women with endometrial cancer are at increased risk of local recurrence and cancer-specific death compared to younger women. We sought to investigate adjuvant radiotherapy (RT) practice patterns and...
14.
Torgeson A, Lloyd S, Boothe D, Tao R, Whisenant J, Garrido-Laguna I, et al.
Cancer
. 2017 Jun;
123(19):3816-3824.
PMID: 28621885
Background: The role of chemoradiotherapy (CRT) in locally advanced pancreatic cancer (LAPC) is uncertain after multiple randomized clinical trials have yielded mixed results. The authors used the National Cancer Data...
15.
Boothe D, Williams N, Odei B, Poppe M, Werner T, Suneja G, et al.
Int J Gynecol Cancer
. 2017 May;
27(5):912-922.
PMID: 28498257
Objective: Early-stage high-risk endometrial cancer (HREC) treated with adjuvant radiotherapy (aRT) alone has been associated with an increased risk of distant relapse. The addition of chemotherapy to radiotherapy (aCRT) may...
16.
Bingham B, Orton A, Boothe D, Stoddard G, Huang Y, Gaffney D, et al.
Int J Radiat Oncol Biol Phys
. 2017 Mar;
97(5):1040-1050.
PMID: 28332987
Purpose: To evaluate the survival benefit of adding vaginal brachytherapy (BT) to pelvic external beam radiation therapy (EBRT) in women with stage III endometrial cancer. Methods And Materials: The National...
17.
Odei B, Boothe D, Suneja G, Werner T, Gaffney D
Am J Clin Oncol
. 2017 Jan;
41(8):784-791.
PMID: 28121642
Objectives: Uterine carcinosarcoma (UCS) is a rare and aggressive cancer with poor survival. Our purpose was to evaluate the patterns-of-care and overall survival (OS) benefit of adjuvant chemoradiation (aCRT) compared...
18.
Odei B, Frandsen J, Boothe D, Ermoian R, Poppe M
Int J Radiat Oncol Biol Phys
. 2016 Nov;
97(1):60-63.
PMID: 27816365
Purpose: Proton beam therapy (PBT) potentially allows for improved sparing of normal tissues, hopefully leading to decreased late side effects in children. Using a national registry, we sought to perform...
19.
Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe M, et al.
Gynecol Oncol
. 2016 Oct;
143(3):690-691.
PMID: 27726921
No abstract available.
20.
Boothe D, Hopkins Z, Frandsen J, Lloyd S
J Gastrointest Oncol
. 2016 Aug;
7(4):580-7.
PMID: 27563448
Background: Extrahepatic cholangiocarcinoma (EHC) is a rare malignancy with a relatively poor prognosis. There are no randomized, prospective data to help define the optimal method of radiation delivery for unresectable...